Exporatory clinical study for newly developed drug therapy for preeclampsia with oral nicotinamide
Not Applicable
- Conditions
- preeclampsia
- Registration Number
- JPRN-UMIN000029418
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1)pulmonary edema 2)HELLP syndrome 3)non reasuring fetal status 4)estimated fetal body weight<1.5SD oligohydramnios: maximum vertical pocket<2cm intermittent or retrograde umbilical blood flow 5)genital bleeding of unknown origin 6)progression of premature labor 7)allegey for nicotinamide 8)dangerous situations for mother or fetus evaluated by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prolongation of gestational period
- Secondary Outcome Measures
Name Time Method